cholic acid has been researched along with Insulin Resistance in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 4 (44.44) | 2.80 |
Authors | Studies |
---|---|
Ao, J; Chiba, T; Fujita, N; Iwanaga, T; Kan, M; Kanayama, K; Kanogawa, N; Kanzaki, H; Kato, J; Kato, N; Kishimoto, T; Kiyono, S; Kobayashi, K; Kojima, R; Kondo, T; Koroki, K; Ma, Y; Muroyama, R; Nakagawa, R; Nakamoto, S; Nakamura, M; Ogasawara, S; Saito, T; Sakuma, T; Unozawa, H | 1 |
Aly, RG; Alzaim, I; El-Mallah, A; El-Yazbi, AF; Shaaban, HH; Wahid, A | 1 |
Castaño Mayan, D; Chacko, S; Cheng, CY; Cheng, P; Chèvre, R; Cochran, BJ; Corlianò, M; Drum, C; Flannick, J; Goggi, JL; Groen, AK; Hartimath, SV; Hayden, MR; Kuipers, F; Peng, J; Ramasamy, B; Rye, KA; Sem, KP; Sim, X; Singaraja, RR; Tan, HC; Tan, LJ; Tan, RS; van Dam, RM; van Dijk, TH; Zhong, S | 1 |
Briand, F; Combes, G; Duparc, T; Martinez, LO; Merian, J; Najib, S; Sulpice, T; Trenteseaux, C | 1 |
Aliakbarian, H; Chaudhari, SN; Devlin, AS; Harris, DA; Henke, MT; Luo, JN; Sheu, EG; Subramaniam, R; Tavakkoli, A; Vernon, AH | 1 |
Adams, AC; Hillgartner, FB; Ippagunta, SM; Kharitonenkov, A | 1 |
de Haan, W; Groen, AK; Hayden, MR; Kaur, A; Patankar, JV; Ruddle, P; Singaraja, RR; Verchere, CB; Wijesekara, N | 1 |
Boverhof, R; Jonkers, IJ; Kuipers, F; Masclee, AA; Princen, HM; Romijn, JA; Smelt, AH; Stellaard, F | 1 |
Chan, L; Ma, K; Moore, DD; Saha, PK | 1 |
1 trial(s) available for cholic acid and Insulin Resistance
Article | Year |
---|---|
Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia.
Topics: Bezafibrate; Bile Acids and Salts; Blood Glucose; Body Mass Index; Chenodeoxycholic Acid; Cholesterol; Cholic Acid; Clofibric Acid; Cross-Over Studies; Fasting; Fish Oils; Gallstones; Humans; Hypertriglyceridemia; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Triglycerides | 2006 |
8 other study(ies) available for cholic acid and Insulin Resistance
Article | Year |
---|---|
A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis.
Topics: Animals; Cholesterol; Cholic Acid; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Fibrosis; Fructose; Insulin Resistance; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Triglycerides | 2022 |
Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Benzhydryl Compounds; Biomarkers; Cholesterol; Cholic Acid; Diet, High-Fat; Fibrosis; Glucosides; Inflammation; Insulin Resistance; Liver; Metformin; Non-alcoholic Fatty Liver Disease; Pioglitazone; Rats | 2022 |
Haploinsufficiency of CYP8B1 associates with increased insulin sensitivity in humans.
Topics: Bile Acids and Salts; Cholic Acid; Glucose; Haploinsufficiency; Humans; Insulin; Insulin Resistance; Steroid 12-alpha-Hydroxylase | 2022 |
Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Cholesterol, Dietary; Cholic Acid; Diet; Diet, High-Fat; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Liraglutide; Liver; Liver Cirrhosis; Metabolic Diseases; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2019 |
Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects.
Topics: Animals; Anti-Obesity Agents; Bariatric Surgery; Bile; Caco-2 Cells; Cholic Acid; Colon; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucose Tolerance Test; HEK293 Cells; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Receptors, G-Protein-Coupled; RNA, Small Interfering; Signal Transduction; Sulfates | 2021 |
Cholic Acid Supplementation of a High-Fat Obesogenic Diet Suppresses Hepatic Triacylglycerol Accumulation in Mice via a Fibroblast Growth Factor 21-Dependent Mechanism.
Topics: Acetyl-CoA Carboxylase; Adipose Tissue; Animals; Blood Glucose; Cholic Acid; Diet, High-Fat; Dietary Fats; Dietary Supplements; Energy Metabolism; Fatty Acids; Fatty Liver; Fibroblast Growth Factors; Insulin; Insulin Resistance; Lipogenesis; Liver; Male; Mice; Mice, Knockout; Obesity; Signal Transduction; Sterol Esterase; Triglycerides | 2018 |
Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1.
Topics: Animals; Cholic Acid; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucose; Homeostasis; Insulin; Insulin Resistance; Insulin-Secreting Cells; Mice; Mice, Knockout; Steroid 12-alpha-Hydroxylase | 2015 |
Farnesoid X receptor is essential for normal glucose homeostasis.
Topics: Animals; Cholic Acid; DNA-Binding Proteins; Gluconeogenesis; Glucose; Homeostasis; Insulin Resistance; Kidney; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Biological; Muscle, Skeletal; Receptors, Cytoplasmic and Nuclear; Suppression, Genetic; Time Factors; Transcription Factors | 2006 |